Acute natural killer cell pneumonia in a patient transplanted with autologous haematopoietic stem cells for systemic sclerosis

Rheumatology (United Kingdom)

Volumn 52, Issue 5, 2013, Pages 954-956

  Chizzolini, Carlo ^a   Vukicevic, Marija ^a   Rochat, Thierry ^a   Tyndall, Alan ^b   Roosnek, Eddy ^a  

^a University Hospital and Faculty of Medicine   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; METHOTREXATE; PREDNISOLONE; VALACICLOVIR;

ADULT; ARTHRALGIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD GAS ANALYSIS; CASE REPORT; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL STRAIN K 562; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; DISEASE COURSE; DRUG MEGADOSE; DRUG PULSE THERAPY; DYSPNEA; FEMALE; FEVER; HEMATOPOIESIS; HUMAN; HYPERCAPNIA; HYPOXEMIA; INFECTION PREVENTION; INFLAMMATORY CELL; LETTER; LOW DRUG DOSE; LUNG LAVAGE; LYMPHOCYTE COUNT; MYALGIA; NATURAL KILLER CELL; PRIORITY JOURNAL; SKINFOLD; SYSTEMIC SCLEROSIS; VIRUS DETECTION; VIRUS PNEUMONIA;

ADULT; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; PNEUMONIA; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; TRANSPLANTATION, AUTOLOGOUS;

EID: 84876725553     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes276     Document Type: Letter

References (10)

1. van Laar JM, Farge D, Tyndall A. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. Ann Rheum Dis 2005;64:1515.
2. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004;104:3664.
3. Foley B, Cooley S, Verneris MR et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2011;119:2665.
4. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005;5: 201-14.
5. Zamora MR. DNA viruses (CMV, EBV, and the herpesviruses). Semin Respir Crit Care Med 2011;32:454-70.
6. Barry SM, Johnson MA, Janossy G. Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant 2000;26:591-7.
7. Grundy JE, Shanley JD, Griffiths PD. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 1987;2:996-9.
8. Culley FJ. Natural killer cells in infection and inflammation of the lung. Immunology 2009;128:151-63.
9. Vukicevic M, Chalandon Y, Helg C et al. CD56-bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells. Eur J Immunol 2010;40: 3246-54.
10. Horikawa M, Hasegawa M, Komura K et al. Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. J Invest Dermatol 2005;125:731-7.